Peptide skincare claims on TikTok: what the science says

What's this video probably claiming?

Based on the caption referencing "sm progress" alongside the peptide and skincare hashtags, @youcanrelatetosasha is almost certainly documenting a personal skincare journey, likely centered on topical or injectable peptides, with GHK-Cu (copper tripeptide-1) being the most probable candidate given its current TikTok dominance. The "still not clear" framing suggests the creator is tracking an acne, texture, or pigmentation concern. This is a familiar format: relatable creator, before-and-after implication, anecdotal progress report. What it almost certainly is not doing is telling you what concentration was used, what the comparison period was, or whether any other variables changed. That context gap matters enormously when evaluating any peptide claim for skin.

What does the science actually show?

Let's be honest about the evidence base here. GHK-Cu has genuinely interesting preclinical data. A 2015 review by Pickart and Margolina in the journal Cosmetics summarized decades of in vitro work showing GHK-Cu stimulates collagen synthesis and has antioxidant properties. But in vitro is not a face. The human trial data is thin and largely industry-funded. One oft-cited study by Leyden et al. (2018, Journal of Cosmetic Dermatology) tested a GHK-Cu-containing cream in 67 participants over 12 weeks and found modest improvements in fine lines, but the formulation contained multiple actives. For BPC-157 and TB-500, the literature is almost entirely rodent-based. There are zero peer-reviewed randomized controlled trials in humans for injectable peptide use in aesthetic dermatology as of early 2025. That is not a minor caveat. That is the entire evidentiary situation.

Where does the social media noise diverge from clinical reality?

TikTok peptide content has a predictable structure: personal testimony, fast results implication, and heavy use of words like "healing" and "reset." The actual clinical picture is slower and messier. Topical peptides face a significant bioavailability problem. Human skin is an excellent barrier. Peptides larger than roughly 500 daltons have poor transdermal penetration without delivery technology like liposomes or microneedling. GHK-Cu has a molecular weight of about 340 daltons, which is borderline, but most consumer products do not disclose whether the delivery system supports actual dermal absorption. For injectable peptides used off-label for skin, like BPC-157 or semax, the regulatory situation is completely different. These are not FDA-approved for any use. Compounded versions exist but quality varies by pharmacy, and no clinical evidence supports aesthetic applications specifically. Calling that a "skincare routine" blurs a line that regulators care about significantly.

What should you actually know?

If you are watching creators document skincare progress on peptides, a few things are worth keeping straight. First, anecdote is not data, even charming, relatable anecdote with good lighting. Second, peptides are a broad category. A topical copper peptide cream from a cosmetics brand and an injectable research peptide are not comparable products in terms of risk profile, regulatory status, or evidence. Third, real skin improvements take 12 to 16 weeks minimum to evaluate meaningfully because of keratinocyte turnover cycles. Progress at 4 or 6 weeks may reflect hydration changes, not structural skin remodeling. Fourth, if a creator is using peptides beyond topical cosmetics, specifically injectable or intranasal compounds, that involves a different risk conversation that requires a licensed provider, not a TikTok comment section. Progress is real. The explanation for that progress is often far more complicated than the caption suggests.